In April, the FDA debuted a real-time clinical trial model that will allow the agency to monitor safety signals as the trial is being conducted. The first trials were launched in partnership with Houston-based University of Texas MD Anderson Cancer…
The Latest
Researchers at the University of California, Irvine, have found that some antibody-drug conjugates, an emerging class of targeted cancer therapies, were associated with serious infection-related complications, including hospitalization and intensive care admissions. The study analyzed treatment data from 3,511 patients…
Most pharmacy leaders track vacancies and recruiting spend. Far fewer see the full cost of turnover as it spreads into capacity, resilience and the ability to execute strategic priorities. This live webinar will examine what leaders are missing about pharmacy…
Jun 24, 2026 1:00 PM - 2:00 PM CDT
Presenters
Tina Moan, PharmD
Julie Lanza CPhT-Adv, CSPT, CPTEd, FMSHP
Health systems face mounting pressure to optimize capacity, improve patient flow and time capital investments correctly. Traditional planning tools rely on averages that flatten the real variability of patient acuity, arrivals and clinical decision-making, leaving leaders with incomplete insight into…
Presented by:
Fewer than 10% of cancer patients undergo hereditary testing — meaning the vast majority of high-risk individuals are never identified within standard clinical workflows. VHC Health found a way to change that. By integrating a digital tool to automatically capture…
Jul 9, 2026 1:00 PM - 2:00 PM CDT
Presented by:
Presenters
Stephanie Spaulding, MGC, CGC
Genetic Counseling Clinical Manager, VHC Health
Roughly 1 in 20 individuals carry a genetic mutation that increases their risk for cancer, yet most remain unaware. As precision medicine advances and access to genetic testing expands, the ability to identify at-risk patients has never been more attainable.…
Presented by:
Norfolk, Va.-based Sentara Health will launch the first vertically integrated theranostics program in Virginia. The program will be established in partnership with biotechnology firm BAMF Health, according to a May 28 news release from Sentara Health. Theranostics offers treatment for…
Revenue cycle teams are under pressure to protect margins while navigating growing denial complexity, staffing shortages and increasing payer scrutiny. As payer behavior accelerates and reimbursement timelines tighten, recovery alone may no longer be enough. In this white paper, learn…
Presented by:
AI agents are already processing prior authorizations, adjudicating claims and driving member outreach at scale. But an agent is only as trustworthy as the data grounding it. When member identities, benefits and authorizations are fragmented, agents make confident but wrong…
Jul 23, 2026 11:00 AM - 12:00 PM CDT
Presented by:
Presenters
Chris Pierpan
Senior Director, Communities of Practice
A personalized mRNA cancer vaccine combined with immunotherapy cut melanoma recurrence risk by 49%, according to a study published June 1 in the Journal of Clinical Oncology and simultaneously presented at the American Society of Clinical Oncology annual meeting in…